Department of Neurosurgery, Padua University Hospital;
J Neurosurg. 2014 Apr;120(4):840-5. doi: 10.3171/2013.12.JNS131642. Epub 2014 Jan 10.
Bone invasion is a major concern in meningioma surgery, since it is predictive of the recurrence of cranial involvement, morbidity, and mortality. Bone invasion has been reported in 20%-68% of studies with histopathologically confirmed data. Unfortunately, radical resection of bone invasion remains challenging. The aim of this study was to assess the role of 5-aminolevulinic acid (5-ALA) fluorescence in guiding the resection of bone-invading meningiomas. To this purpose, the sensitivity, specificity, and positive and negative predictive values of 5-ALA in detecting meningioma bone invasion were evaluated.
Data from 12 patients affected by bone-invading meningiomas (7 with skull base and 5 with convexity meningiomas) who had undergone surgery with the assistance of 5-ALA fluorescence and neuronavigation between July 2012 and March 2013 at the Department of Neurosurgery of Padua were retrospectively analyzed. To evaluate the sensitivity and specificity of 5-ALA fluorescence in detecting meningioma tissue, a pathologist analyzed 98 surgical bone samples under blue light, according to different fluorescence patterns. Magnetic resonance images and CT scans were obtained pre- and postoperatively to determine the extent of bone invasion resection.
The rate of 5-ALA-induced fluorescence of both tumor and bone invasion was 100%. Based on the pathological examination of bone specimens, 5-ALA presented a sensitivity of 89.06% (95% CI 81.41%-96.71%) and a specificity of 100% in detecting meningioma bone invasion, while the positive and negative predictive values were 100% and 82.93% (95% CI 71.41%-94.45%), respectively. At the postoperative stage, MRI did not detect cases of meningioma bone invasion, whereas CT scans revealed residual hyperostosis in 2 cases.
In summary, 5-ALA fluorescence represents a suitable and reliable technique for identifying and removing bone infiltration by meningiomas. However, further studies are needed to prove the clinical consequences of this promising technique in a larger population.
骨侵犯是脑膜瘤手术中的一个主要关注点,因为它预示着颅外侵犯、发病率和死亡率的复发。有研究报道称,在组织病理学确诊数据中,骨侵犯的发生率为 20%-68%。不幸的是,根治性切除骨侵犯仍然具有挑战性。本研究旨在评估 5-氨基乙酰丙酸(5-ALA)荧光在指导脑膜瘤骨侵犯切除中的作用。为此,评估了 5-ALA 检测脑膜瘤骨侵犯的敏感性、特异性、阳性和阴性预测值。
回顾性分析了 2012 年 7 月至 2013 年 3 月期间在帕多瓦神经外科部门接受了 5-ALA 荧光和神经导航辅助手术的 12 例骨侵犯脑膜瘤患者(7 例颅底脑膜瘤和 5 例凸面脑膜瘤)的数据。为了评估 5-ALA 荧光在检测脑膜瘤组织中的敏感性和特异性,病理学家根据不同的荧光模式,对 98 例手术骨样本在蓝光下进行了分析。在术前和术后均获得磁共振成像和 CT 扫描,以确定骨侵犯切除的范围。
肿瘤和骨侵犯的 5-ALA 诱导荧光率均为 100%。基于骨标本的病理检查,5-ALA 检测脑膜瘤骨侵犯的敏感性为 89.06%(95%CI 81.41%-96.71%),特异性为 100%,阳性预测值为 100%,阴性预测值为 82.93%(95%CI 71.41%-94.45%)。在术后阶段,MRI 未检测到脑膜瘤骨侵犯病例,而 CT 扫描显示 2 例有残余骨过度增生。
总之,5-ALA 荧光是一种识别和切除脑膜瘤骨浸润的合适且可靠的技术。然而,需要进一步的研究来证明这项有前途的技术在更大人群中的临床意义。